Linvoseltamab, now Lynozyfic, earns EU’s conditional OK to treat RRMM
The European Commission (EC) has conditionally approved…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Trial data for 2 Caribou CAR T-cell therapies due this year
Caribou Biosciences is reprioritizing its pipeline to focus on…
Myeloma quiz: Stages and progression
A short quiz focused on the stages of multiple myeloma, including how the disease is classified and what each stage indicates. It offers a clear snapshot of how myeloma can progress and what staging means for disease management.
Blenrep combos approved in UK as multiple myeloma treatment
The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA)…
Myeloma quiz: Understanding the basics
A brief quiz highlighting the fundamentals of myeloma, from its causes and diagnosis to the areas it affects and treatment options. Designed to support learning and awareness, it offers a helpful overview of this complex blood cancer.
Europe extends Darzalex approval as multiple myeloma treatment
The European Commission has extended its approval of Johnson…
